Evidence map›Paper›PMID 41480204›Full record

ArticleWorld journal of gastrointestinal oncology2025

Beyond the blank page: Frequentist and Bayesian perspectives on risk prediction algorithms.

Francisco Tustumi, Felipe Antonio Boff Maegawa, Pedro Luiz Serrano Uson Junior

Abstract readLetter
In one paragraph

Article in World journal of gastrointestinal oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Francisco TustumiCenter for Personalized Medicine, Hospital Israelita Albert Einstein, São Paulo 05652900, Brazil.
Felipe Antonio Boff MaegawaSurgery, Emory University, Atlanta, GA 30322, United States.
Pedro Luiz Serrano Uson JuniorCenter for Personalized Medicine, Hospital Israelita Albert Einstein, São Paulo 05652900, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Risk prediction has long been a cornerstone of surgical oncology, enabling surgeons to anticipate complications, tailor perioperative care, and improve outcomes. With the rise of artificial intelligence, machine learning (ML) models are increasingly being applied to predict outcomes, highlighting the growing significance of data-driven methods for clinical decision-making. Currently, frequentist approaches dominate prediction models, including most ML algorithms; these rely exclusively on observed datasets and risk overlooking the cumulative value of prior clinical knowledge. In contrast, Bayesian reasoning formally integrates existing evidence with new data. In this letter, we examine the strengths of frequentist-based prediction models, discuss how Bayesian methods may improve predictive accuracy, and argue that combining both approaches offers a promising path toward more robust, interpretable, and clinically useful prediction tools in surgery. This integration can yield robust, interpretable, and clinically relevant tools that advance personalized surgical care.

Indexed as

Artificial intelligenceBayes theoremGastric cancerPrediction algorithmsProbability learningRisk

Identifiers

PMID41480204
PMCPMC12754308

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.